Compare Home Depot Inc (HD) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Home Depot Inc vs TransMedics Group Inc — how do they compare? Home Depot Inc trades at $331.02 (market cap $332.08B), while TransMedics Group Inc trades at $73.5 (market cap $2.54B). The key difference: Home Depot Inc is far larger — about 130.7× TransMedics Group Inc's market cap, and Home Depot Inc pays a 2.8% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| HD | TMDX | |
|---|---|---|
Market Cap | $332.08B | $2.54B |
Sector | Consumer Cyclical | Technology |
52-Week High | $423.42 | $150.42 |
52-Week Low | $297.51 | $61.99 |
Enterprise Value | $393.64B | $2.94B |
Dividend Yield | 2.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Home Depot (HD) trades at $331.6, down 2.15% recently, near its 52-week low amid a bearish technical signal. The company reported mixed quarterly earnings, with Q2 2026 results pending, and maintains solid profitability with a net margin of 8.41% and ROE of 128.38%. Revenue grew to $159.51B in 2025, though margins have softened, and cash flow trends show volatility with a net outflow of $2.10B in 2025.
The outlook is cautious due to weak housing demand and rising mortgage rates pressuring big-ticket sales, but long-term prospects are supported by Pro customer growth and analyst optimism with a $370.59 consensus target. Key risks include competitive pressures and economic sensitivity, while institutional activity shows mixed positioning.
TransMedics (TMDX) is trading at $73.47, down 0.69% on the day, amid a mixed technical and fundamental backdrop. The stock shows neutral technical signals with support near $72 and resistance at $75, while fundamentals are strong with a trailing P/E of 16.81 and robust profitability metrics like a 27.04% net income margin. Recent earnings saw a Q1 2026 miss but beats in prior quarters, and the company is expanding in Europe through strategic investments.
The outlook is cautiously optimistic with a consensus price target of $108.71 implying significant upside, supported by 75% analyst buy ratings. Key risks include margin pressure from expansion costs and competitive threats, but the company's organ transplant logistics network offers a durable competitive advantage for long-term growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
